ÂÜÀòÂÒÂ×

Andrew Moniz is currently the Vice President Therapeutic Strategy & Innovation at Syneos Health. Prior to that, Andrew held various leadership positions in companies like INC Research, Neuralstem, Inc., Worldwide Clinical Trials, i3, Celeris, PAREXEL, and UCB Pharma. With a background in Experimental Psychology from the University of Kentucky and a BA in Psychology from Salve Regina University, Andrew has extensive experience in clinical development, clinical trials operations, global alliance management, project management, and data management in the pharmaceutical industry.